Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ephedrine Hydrichloride and Nitrofurazone Nasal Drops

Approval Number

国药准字H32026071

Company上海旭东海普南通药业有限公司

Registration Date

May 26, 2021

Previous Approval Numbers

国药准字H32026071

Drug Information

Generic Name

呋麻滴鼻液

Dosage Form

鼻用制剂

Strength

10ml

Drug Type

化学药品

Registration Date

May 26, 2021

Company Information

Applicant Company

Company Name上海旭东海普南通药业有限公司

Company Address

江苏省如东县陈高工业园区9号

Manufacturing Company

Company Name上海旭东海普南通药业有限公司

Company Address

江苏省如东县陈高工业园区9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy